Archangels Lead a £4 Million Fund to Cytomos

Current Archangel investors carried out the funding round, which also included Old College Capital, Scottish Enterprise, and a new shareholder, British Business Bank.

Cytomos will be able to significantly boost the development of their workforce and accelerate the enhancement of its innovations, thanks to new financing.

Sarah Hardy, Manager of new funding at Archangels stated, “As a highly innovative, Scottish early-stage life science company with global horizons, Cytomos is an excellent fit for our investment portfolio.”

She went on to say, “We’re looking forward to working with David and the team as they drive the business forward, making smarter, faster and more accurate cell analysis finally more accessible.”

© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.